Theravance Inc - THRX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Theravance Inc - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
THRX	Nasdaq	2834	http://www.theravance.com	35.71 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Theravance Inc Is Elan Pushing Its Luck? - Jun 18th, 2013 4:58 pm Royalty Pharma abandons bid for Elan - Jun 18th, 2013 11:29 am Royalty drops hostile bid for Ireland's Elan - Jun 18th, 2013 7:00 am Royalty drops hostile bid for Ireland's Elan - Jun 18th, 2013 7:00 am Royalty drops hostile bid for Ireland's Elan - Jun 18th, 2013 6:56 am Royalty drops hostile bid for Ireland's Elan - Jun 18th, 2013 6:55 am Elan holders OK buyback, vote down 3 deals - Jun 17th, 2013 4:49 pm Elan holders OK buyback, vote down 3 deals - Jun 17th, 2013 4:49 pm Theravance Larger Than S&P 500 Component E*trade Financial Corporation - Jun 17th, 2013 2:39 pm Elan Investors Approve Buyback to Force Royalty Bid End - Jun 17th, 2013 2:05 pm Elan Explores Sale Options - Jun 17th, 2013 2:00 pm Elan Shareholders Bring Management To Heel - Jun 17th, 2013 11:45 am Theravance Will Split Into 2 Companies After Losing Elan Bid - Jun 17th, 2013 11:32 am Theravance to proceed with plan to split business - Jun 17th, 2013 8:13 am Theravance to proceed with plan to split business - Jun 17th, 2013 8:13 am Elan Shareholders Do Not Approve Theravance/Elan Royalty Participation Transaction - Jun 17th, 2013 6:18 am Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now - Jun 17th, 2013 5:44 am Royalty hostile bid for Elan in doubt after vote - Jun 17th, 2013 4:53 am Royalty hostile bid for Elan in doubt after vote - Jun 17th, 2013 4:51 am Royalty hostile bid for Elan in doubt after vote - Jun 17th, 2013 4:51 am View All Current Headlines >>